4.96
-0.03 (-0.50%)
| Penutupan Terdahulu | 4.98 |
| Buka | 5.05 |
| Jumlah Dagangan | 162,349 |
| Purata Dagangan (3B) | 234,534 |
| Modal Pasaran | 183,803,248 |
| Harga / Jualan (P/S) | 66.02 |
| Harga / Buku (P/B) | 56.83 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 10 Jun 2025 - 25 Jun 2025 |
| Margin Operasi (TTM) | -4,013.86% |
| EPS Cair (TTM) | -1.98 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -1.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.23% |
| Nisbah Semasa (MRQ) | 4.51 |
| Aliran Tunai Operasi (OCF TTM) | -61.24 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -43.65 M |
| Pulangan Atas Aset (ROA TTM) | -88.08% |
| Pulangan Atas Ekuiti (ROE TTM) | -186.24% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menurun | Bercampur |
| Medical Instruments & Supplies (Global) | Menurun | Menurun | |
| Stok | Anteris Technologies Global Cor | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.04% |
| % Dimiliki oleh Institusi | 49.10% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| L1 Capital Pty Ltd | 31 Dec 2024 | 2,788,683 |
| One68 Global Capital, Llc | 31 Dec 2024 | 288,914 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 May 2025 | Pengumuman | Anteris Announces Results for the First Quarter of 2025 |
| 31 Mar 2025 | Pengumuman | Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV |
| 21 Mar 2025 | Pengumuman | Anteris Reports One-Year Patient Outcomes for DurAVR® THV |
| 12 Mar 2025 | Pengumuman | Anteris Reports 2024 Financial Results and Provides Corporate Update |
| 28 Feb 2025 | Pengumuman | Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |